Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans

Clinical Pharmacology and Therapeutics

Volumn 62, Issue 2, 1997, Pages 138-144

  Boulton, David W ^a   Fawcett, J Paul ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG POTENCY; ENANTIOMER; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL;

ADMINISTRATION, ORAL; ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; BIOLOGICAL AVAILABILITY; BLOOD GLUCOSE; CROSS-OVER STUDIES; ELECTROCARDIOGRAPHY; HEART RATE; HUMANS; ISOMERISM; MALE; POTASSIUM;

EID: 0030819181     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90061-8     Document Type: Article

References (16)

1. Price AH, Clissold SP. Salbutamol in the 1980s: a reappraisal of its clinical efficacy. Drugs 1989;38:77-122.
2. Patil PN, Millter DD, Trendelenberg U. Molecular geometry and adrenergic drug activity. Pharmacol Rev 1975;26:323-92.
3. 2-agonist therapy: vox clamantis in deserto vel lux in tenebris? J Allergy Clin Immunol 1995;9:641-51.
4. Sanjar S, Kristersson A, Mazzoni L, Morley J, Schaeublin E. Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline. J Physiol 1990;425:43-54.
5. Morley J, Chapman ID, Foster A, Hoshiko K, Mazzoni L. Effects of (+)- and racemic salbutamol on airway responses in the guinea-pig [abstract]. Br J Pharmacol 1991;104:295P.
6. Perrin-Fayolle M. Salbutamol in the treatment of asthma [letter]. Lancet 1995;346:1101.
7. Boulton DW, Fawcett JP. Determination of salbutamol enantiomers in human plasma and urine by chiral high-performance liquid chromatography. J Chromatogr B Biomed Appl 1995;672:103-9.
8. Boulton DW, Fawcett JP. Enantioselective disposition of salbutamol in man following oral and intravenous administration. Br J Clin Pharmacol 1996;41:35-40.
9. Baba S, Goromaru T, Kawaguchi I, Kishi K. Urinary excretion of salbutamol enantiomers in man by stable isotope tracer technique. Iyakuhin Kenkyu 1981;12:84-90.
10. Tan YK, Soldin SJ. Determination of salbutamol in human serum by reversed-phase high-performance liquid chromatography with amperometric detection. J Chromatogr Biomed Appl 1984;311:311-7.
11. Walle T, Walle UK, Thornburg KR, Schey KL. Stereoselective sulfation of albuterol in humans: biosynthesis of the sulfate conjugate by HEP G2 cells. Drug Metab Dispos 1993;21:76-80.
12. Reed CE. Adrenergic bronchodilators: pharmacology and toxicology. J Allergy Clin Immunol 1985;76:335-41.
13. Funck-Brentano C, Jaillon P. Rate corrected QT interval: techniques and limitations. Am J Cardiol 1993; 72:17B-22B.
14. 2-agonist drug albuterol in the human liver. Res Commun Chem Pathol Pharmacol 1992;75:125-8.
15. Hartley D, Middlemiss D. Absolute configuration of the optical isomers of salbutamol. J Med Chem 1971;14:895.
16. Hawkins CJ, Klease GT. Relative potency of (-)- and (±)-salbutamol on guinea pig tracheal tissue. J Med Chem 1973;16:856-7.